Medical Plastics Market See Large Application Potential In Customized, Patient-Friendly Implants The medical industry world over has been benefitting from the wide range of devices, equipment, and implants made with high performance plastics. Sellers and manufacturers in the global medical plastics market are reaping revenue gains by leveraging the versatility, safety, and cost-effectiveness of medical-grade plastics in these applications. In addition, the freedom that medical grade plastics offer to fabricators has helped bolster their application, underpinning the evolution of the medical grade plastics market, notes Transparency Market Research (TMR). Manufacturers over the recent decade have been increasingly adopting high technology polymers in making devices that will be used for various stages in disease management and surgeries. Unique set of characteristics of plastics have enabled manufacturers in medical plastics market replace titanium/stainless steel metals with plastics, such as in medical tubing. The global medical plastics market is projected to clock a CAGR of 7.2% from 2019 to 2027 and reach valuation of US$15.4 bn by the end of the period. The competitive landscape in the global medical plastics market is characterized by the presence of several small- and medium-scale players. Further, the shares are fairly distributed among numerous players. Well-entrenched manufacturers in the medical plastics market are forking out money for constant capacity expansion and are engaging in mergers to consolidate their position globally. Some of them are The Lubrizol Corporation, Solvay, Covestro AG, Arkema S.A., and Evonik Industries AG. The range of medical-grade plastics available for application are vast. Major of them are PVC, PE, PP, PS, engineering plastics, and silicone. Though the use of conventional plastics still rules the roost, engineered thermoplastics are gathering steam among manufacturers in the medical plastics market.